Syrma SGS Technology Files Monitoring Agency Report for IPO Proceeds Utilisation for Quarter Ended March 31, 2026
Syrma SGS Technology Limited filed its Monitoring Agency Report for the quarter ended March 31, 2026, prepared by Crisil Ratings Limited, confirming no deviation from IPO proceeds utilisation as per the Offer Document. Cumulative net proceeds utilised stood at Rs 6,813.50 million out of Rs 7,257.22 million, with Rs 80.71 million deployed during the quarter towards capital expenditure. The remaining unutilised balance of Rs 443.72 million is parked in fixed deposits and a monitoring agency bank account, with the company planning to deploy the balance in Fiscal Year 2027.

*this image is generated using AI for illustrative purposes only.
Syrma SGS Technology Limited has filed its Monitoring Agency Report for the quarter ended March 31, 2026, pursuant to Regulation 41(4) of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018. The report has been prepared and submitted by Crisil Ratings Limited, the appointed Monitoring Agency, and is based on a Statutory Auditor Certificate dated May 08, 2026, issued by M/s. Walker Chandio & Co LLP Chartered Accountants (Firm Registration Number: 001076N/N500013). The filing was made on May 12, 2026, by Company Secretary & Compliance Officer Bhabagrahi Pradhan.
IPO Issue Details
The IPO of Syrma SGS Technology Limited was conducted during August 12, 2022, to August 18, 2022. The key parameters of the issue are summarised below:
| Parameter: | Details |
|---|---|
| Issue Period: | August 12, 2022 – August 18, 2022 |
| Type of Issue: | Initial Public Offer (IPO) |
| Type of Securities: | Equity Shares |
| Total Issue Size: | Rs 8,401.26 million |
| Fresh Issuance (Gross Proceeds): | Rs 7,660.00 million |
| Net Proceeds (Monitored): | Rs 7,257.22 million |
| Offer for Sale: | Rs 741.26 million |
| Monitoring Agency: | Crisil Ratings Limited |
Crisil Ratings Limited monitors only the net proceeds amount of Rs 7,257.22 million. The Prospectus is dated August 19, 2022.
Utilisation of IPO Proceeds
The Monitoring Agency confirmed that all utilisation is as per the disclosures in the Offer Document, with no deviation observed. Proceeds were utilised towards capital expenditure and expansion or setting up of manufacturing facilities. The following table presents the progress in utilisation across the three objects of the issue as at the quarter ended March 31, 2026:
| Item Head: | Amount as Proposed (Rs in million) | Utilised at Beginning of Quarter (Rs in million) | Utilised During Quarter (Rs in million) | Utilised at End of Quarter (Rs in million) | Unutilised Amount (Rs in million) |
|---|---|---|---|---|---|
| Funding capital expenditure for R&D facility and manufacturing facilities: | 4,030.00 | 3,517.65 | 80.71 | 3,598.37 | 431.63 |
| Funding working capital requirements: | 1,315.80 | 1,315.13 | – | 1,315.13 | 0.67 |
| General Corporate Purposes: | 1,911.42 | 1,900.00 | – | 1,900.00 | 11.42 |
| Total: | 7,257.22 | 6,732.78 | 80.71 | 6,813.50 | 443.72 |
During the quarter ended March 31, 2026, utilisation of Rs 80.71 million was recorded exclusively under the capital expenditure object. No utilisation was recorded under working capital requirements or general corporate purposes during the quarter. The Monitoring Agency noted that part of the spend was made by transferring net proceeds from the company's monitoring agency account maintained with HDFC Bank to various current accounts for business operational ease, and the transferred amount stands fully utilised as at the end of the reported quarter.
Deployment of Unutilised Proceeds
As at March 31, 2026, the total unutilised amount of Rs 443.72 million is deployed across a monitoring agency bank account and fixed deposits. The deployment details are as follows:
| Instrument: | Amount Invested (Rs in million) | Maturity Date | ROI (%) | Market Value (Rs in million) |
|---|---|---|---|---|
| HDFC Monitoring Agency Account No. 57500000951058: | 14.28 | NA | NA | 14.28 |
| RBL Bank Fixed Deposit – 709029484694: | 203.00 | 27 March 2027 | 7.80% | 203.00 |
| RBL Bank Fixed Deposit – 709029484773: | 205.00 | 27 March 2027 | 7.80% | 205.00 |
| RBL Bank Fixed Deposit – 709029484834: | 205.00 | 27 March 2027 | 7.80% | 205.00 |
| RBL Bank Fixed Deposit – 709029484898: | 205.00 | 27 March 2027 | 7.80% | 205.00 |
| Total: | 832.28 | 832.28 |
The total amount invested includes interest received (net of TDS) aggregating to Rs 372.08 million accrued during the year on closure of fixed deposits, which has been reinvested. The earnings as on March 31, 2026, are reported as NIL, as monitoring of interest income earned from unutilised net proceeds does not form part of the scope of the Monitoring Agency report.
Implementation Schedule and Delays
The original implementation schedule as per the Prospectus dated August 19, 2022, envisaged complete utilisation of all three objects by Fiscal 2024. The company subsequently revised its implementation schedule to Fiscal 2026; however, as at the end of fiscal 2026, the full amounts remain not completely utilised. The delay in capital expenditure utilisation is attributed to a global shortage of memory chips and semiconductors, which caused certain pipeline orders to be put on hold, leading the company to defer its investment plans. For working capital and general corporate purposes, the company has substantially utilised the proceeds, with small portions remaining unutilised due to timing differences and improved operational cash flows.
The Monitoring Agency report confirms no deviation from the objects of the issue, no change in the means of finance, and no major deviation over earlier monitoring agency reports. The company has indicated that the balance amounts will be utilised in Fiscal Year 2027, consistent with the provision in the Offer Document permitting deployment of net proceeds in subsequent fiscals if unutilised within the originally estimated schedule.
Historical Stock Returns for Syrma SGS
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.68% | -2.14% | +19.23% | +15.99% | +91.19% | +233.54% |
Given that the global semiconductor shortage caused Syrma SGS to defer its capex plans twice, how might further supply chain disruptions impact the company's ability to fully utilise the remaining Rs 431.63 million in R&D and manufacturing capex by Fiscal 2027?
With Rs 443.72 million in unutilised IPO proceeds still parked in fixed deposits maturing in March 2027, what specific manufacturing or R&D milestones is Syrma SGS targeting to demonstrate productive deployment of these funds before the deadline?
How could the prolonged delay in completing IPO-funded capacity expansion affect Syrma SGS's competitive positioning in India's electronics manufacturing services sector, particularly as rivals accelerate their own capex programs?


































